• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Considerations for SGLT2 inhibitor use in post-transplantation diabetes.

作者信息

Hecking Manfred, Jenssen Trond

机构信息

Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria.

Department of Organ Transplantation, Section of Nephrology, University Hospital of Oslo and University of Oslo, Oslo, Norway.

出版信息

Nat Rev Nephrol. 2019 Sep;15(9):525-526. doi: 10.1038/s41581-019-0173-0.

DOI:10.1038/s41581-019-0173-0
PMID:31235880
Abstract
摘要

相似文献

1
Considerations for SGLT2 inhibitor use in post-transplantation diabetes.移植后糖尿病使用钠-葡萄糖协同转运蛋白2抑制剂的考量因素
Nat Rev Nephrol. 2019 Sep;15(9):525-526. doi: 10.1038/s41581-019-0173-0.
2
Dapagliflozin-Associated Diabetic Ketoacidosis.达格列净相关的糖尿病酮症酸中毒
Am J Ther. 2018 Nov/Dec;25(6):e765-e766. doi: 10.1097/MJT.0000000000000770.
3
SGLT2-inhibitors in type-2 diabetes: The remaining questions!2型糖尿病中的钠-葡萄糖协同转运蛋白2抑制剂：尚存的问题！
Diabetes Metab Syndr. 2017 Nov;11 Suppl 1:S433-S438. doi: 10.1016/j.dsx.2017.03.031. Epub 2017 Mar 31.
4
Sodium glucose transporter 2 inhibition: a new approach to diabetes treatment.钠-葡萄糖协同转运蛋白2抑制：糖尿病治疗的新方法。
J Diabetes. 2013 Sep;5(3):225-7. doi: 10.1111/1753-0407.12065. Epub 2013 Jul 1.
5
[Life-threatening ketoacidosis in a 25-year-old woman treated with sodium-glucose cotransporter 2 inhibitor].[一名接受钠-葡萄糖协同转运蛋白2抑制剂治疗的25岁女性发生危及生命的酮症酸中毒]
Ugeskr Laeger. 2016 Nov 21;178(47).
6
[Severe atypical ketoacidosis due to SGLT2-inhibitor therapy : Two case reports].[SGLT2抑制剂治疗所致严重非典型酮症酸中毒：两例报告]
Internist (Berl). 2018 Mar;59(3):282-287. doi: 10.1007/s00108-017-0316-y.
7
Empagliflozin Is Associated With a Lower Risk of Post-Acute Heart Failure Rehospitalization and Mortality.恩格列净与急性心力衰竭后再住院及死亡风险降低相关。
Circulation. 2019 Mar 12;139(11):1458-1460. doi: 10.1161/CIRCULATIONAHA.118.038339.
8
The cardiovascular benefits of empagliflozin: SGLT2-dependent and -independent effects.恩格列净对心血管系统的益处：依赖和不依赖SGLT2的作用。
Diabetologia. 2017 Mar;60(3):395-398. doi: 10.1007/s00125-016-4194-y. Epub 2017 Jan 11.
9
Bittersweet: infective complications of drug-induced glycosuria in patients with diabetes mellitus on SGLT2-inhibitors: two case reports.苦乐参半：SGLT2 抑制剂治疗的糖尿病患者因药物引起的糖尿导致的感染性并发症：两例报告。
BMC Infect Dis. 2021 Mar 20;21(1):284. doi: 10.1186/s12879-021-05982-3.
10
Eligibility varies among the 4 sodium-glucose cotransporter-2 inhibitor cardiovascular outcomes trials: implications for the general type 2 diabetes US population.4 项钠-葡萄糖共转运蛋白 2 抑制剂心血管结局试验的入选标准存在差异：对美国一般 2 型糖尿病人群的影响。
Am J Manag Care. 2018 Apr;24(8 Suppl):S138-S145.

引用本文的文献

1
Novel Drugs for the Management of Diabetes Kidney Transplant Patients: A Literature Review.用于糖尿病肾移植患者管理的新型药物：文献综述
Life (Basel). 2023 May 26;13(6):1265. doi: 10.3390/life13061265.
2
Sodium-glucose cotransporter-2 inhibitor therapy in kidney transplant patients with type 2 or post-transplant diabetes: an observational multicentre study.钠-葡萄糖协同转运蛋白2抑制剂治疗2型糖尿病或移植后糖尿病的肾移植患者：一项多中心观察性研究。
Clin Kidney J. 2023 Jan 11;16(6):1022-1034. doi: 10.1093/ckj/sfad007. eCollection 2023 Jun.
3
Prescribing SGLT2 Inhibitors in Patients With CKD: Expanding Indications and Practical Considerations.
为慢性肾脏病患者开具钠-葡萄糖协同转运蛋白2抑制剂：适应证拓展与实际考量
Kidney Int Rep. 2022 May 5;7(7):1463-1476. doi: 10.1016/j.ekir.2022.04.094. eCollection 2022 Jul.
4
Ameliorating Metabolic Profiles After Kidney Transplantation: A Protocol for an Open-Label, Prospective, Randomized, 3-Arm, Controlled Trial.改善肾移植后的代谢状况：一项开放标签、前瞻性、随机、三臂、对照试验方案
Front Med (Lausanne). 2021 Dec 23;8:800872. doi: 10.3389/fmed.2021.800872. eCollection 2021.
5
Successful use of the sodium-glucose co-transporter-2 inhibitor dapagliflozin in patients with renal transplant and diabetes: a case series and literature review.钠-葡萄糖协同转运蛋白2抑制剂达格列净在肾移植合并糖尿病患者中的成功应用：病例系列及文献综述
Cardiovasc Endocrinol Metab. 2021 Mar 17;10(4):222-224. doi: 10.1097/XCE.0000000000000246. eCollection 2021 Dec.
6
Sodium-glucose co-transporter 2 inhibitors: game changers when handled with care?钠-葡萄糖共转运蛋白 2 抑制剂：谨慎使用时的改变游戏规则者？
J R Soc Med. 2021 Jul;114(7):351-358. doi: 10.1177/01410768211011109. Epub 2021 May 4.
7
Sodium-Glucose Cotransporter-2 Inhibitors in Nephrology Practice: A Narrative Review.肾病治疗中钠-葡萄糖协同转运蛋白2抑制剂：一篇叙述性综述
Can J Kidney Health Dis. 2020 Jun 24;7:2054358120935701. doi: 10.1177/2054358120935701. eCollection 2020.
8
Cardiovascular events associate with diabetes status rather than with early basal insulin treatment for the prevention of post-transplantation diabetes mellitus.心血管事件与糖尿病状态相关，而非与预防移植后糖尿病的早期基础胰岛素治疗相关。
Nephrol Dial Transplant. 2020 Mar 1;35(3):544-546. doi: 10.1093/ndt/gfz244.